EFFECTIVENESS OF SHORT TERM NEOADJUVANT ENDOCRINE THERAPY ON KI67 IN LUMINAL BREAST CANCERS

被引：0
|
作者：
Louis, D. [1 ]
Surendran, H. [1 ]
机构：
[1] Amrita Vishwa Vidyapeetham, Kochi, KL, India
来源：
VALUE IN HEALTH | 2022年 / 25卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
CO102
引用
收藏
页码：S323 / S323
页数：1
相关论文
共 50 条
  • [31] Factors Predicting Response in Breast Cancer Receiving Neoadjuvant Therapy and the Role of Ki67 Labeling Index
    Ekinci, Ferhat
    Uzun, Mehmet
    Demir, Bilgin
    Unek, Ilkay Tugba
    Erdogan, Atike Pinar
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2023, 33 (08): : 872 - 878
  • [32] ASO Visual Abstract: Neoadjuvant Chemotherapy and Nodal Response Rates in Luminal Breast Cancer—Effects of Age and Tumor Ki67
    Judy C. Boughey
    Tanya L. Hoskin
    Matthew P. Goetz
    Annals of Surgical Oncology, 2022, 29 : 5757 - 5758
  • [33] Prognostic value of KI-67 proliferation index in luminal breast cancers
    Dokcu, Seref
    Ali-Caparlar, Mehmet
    Cetindag, Oezhan
    Hakseven, Musluh
    Eroglu, Aydan
    CIRUGIA Y CIRUJANOS, 2023, 91 (01): : 1 - 8
  • [34] KI67 AS A PREDICTOR OF CLINICAL RESPONSE TO NEOADJUVANT CHEMOTHERAPY IN TRIPLEPOSITIVE BREAST CANCER
    Ben Hamida, Karim
    Houcine, Yoldez
    Maaoui, Amal
    Hamza, Khedija
    Kamoun, Salma
    Ayadi, Senda
    Chargui, Riadh
    Driss, Maha
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2022, 32 : A59 - A59
  • [35] The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
    Jones, Robin L.
    Salter, Janine
    A'Hern, Roger
    Nerurkar, Ash
    Parton, Marina
    Reis-Filho, Jorge S.
    Smith, Ian E.
    Dowsett, Mitchell
    BREAST CANCER RESEARCH AND TREATMENT, 2009, 116 (01) : 53 - 68
  • [36] Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer
    Tanei, T.
    Shimomura, A.
    Shimazu, K.
    Nakayama, T.
    Kim, S. J.
    Iwamoto, T.
    Tamaki, Y.
    Noguchi, S.
    EJSO, 2011, 37 (02): : 155 - 161
  • [37] The prognostic significance of Ki67 before and after neoadjuvant chemotherapy in breast cancer
    Robin L. Jones
    Janine Salter
    Roger A’Hern
    Ash Nerurkar
    Marina Parton
    Jorge S. Reis-Filho
    Ian E. Smith
    Mitchell Dowsett
    Breast Cancer Research and Treatment, 2009, 116 : 53 - 68
  • [38] Ki67 and proliferation in breast cancer
    Pathmanathan, Nirmala
    Balleine, Rosemary L.
    JOURNAL OF CLINICAL PATHOLOGY, 2013, 66 (06) : 512 - 516
  • [39] Determination of endocrine sensitivity by response of the proliferative marker KI67 after short-term preoperative endocrine therapy and their correlation to oncotype score platform.
    Murillo, Serafin Morales
    Cuds, Ariadna Gasol
    Morillo, Ester Morera
    Morales, Carles Canosa
    Olive, Jordi Mele
    Villellas, Felipe Vilardell
    Sanchez Guzman, Douglas Rene
    Salvia, Antonieta Salud
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [40] Assessment of Ki67 in Breast Cancer: Recommendations from the International Ki67 in Breast Cancer Working Group
    Dowsett, Mitch
    Nielsen, Torsten O.
    A'Hern, Roger
    Bartlett, John
    Coombes, R. Charles
    Cuzick, Jack
    Ellis, Matthew
    Henry, N. Lynn
    Hugh, Judith C.
    Lively, Tracy
    McShane, Lisa
    Paik, Soon
    Penault-Llorca, Frederique
    Prudkin, Ljudmila
    Regan, Meredith
    Salter, Janine
    Sotiriou, Christos
    Smith, Ian E.
    Viale, Giuseppe
    Zujewski, Jo Anne
    Hayes, Daniel F.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2011, 103 (22): : 1656 - 1664
12345